EP 0536316 A4 19931118 - ANTIHYPERCHOLESTEROLEMIC BIS-TRIFLUOROMETHYL-SUBSTITUTED IMIDAZOLINES AND DERIVATIVES THEREOF
Title (en)
ANTIHYPERCHOLESTEROLEMIC BIS-TRIFLUOROMETHYL-SUBSTITUTED IMIDAZOLINES AND DERIVATIVES THEREOF
Publication
Application
Priority
US 53356590 A 19900605
Abstract (en)
[origin: WO9119476A1] Provided are bis-trifluoromethyl-substituted imidazolines, as inhibitors of Acyl-CoA: Cholesterol Acyltransferase (ACAT), processes for their preparation, pharmaceutical compositions, and therapeutic methods for their use as antihypercholesterolemic or antiatherosclerotic agents.
IPC 1-7
IPC 8 full level
A61K 31/415 (2006.01); A61K 31/4166 (2006.01); A61P 3/06 (2006.01); A61P 9/10 (2006.01); C07D 233/22 (2006.01); C07D 233/32 (2006.01); C07D 233/42 (2006.01); C07D 233/44 (2006.01); C07D 233/48 (2006.01); C07D 233/54 (2006.01); C07D 233/70 (2006.01); C07D 233/88 (2006.01); C07D 405/12 (2006.01); C07D 409/12 (2006.01)
CPC (source: EP KR)
A61P 3/06 (2017.12 - EP); A61P 9/10 (2017.12 - EP); C07D 233/22 (2013.01 - EP); C07D 233/48 (2013.01 - EP); C07D 233/64 (2013.01 - EP); C07D 233/66 (2013.01 - KR); C07D 233/70 (2013.01 - EP); C07D 233/88 (2013.01 - EP); C07D 405/12 (2013.01 - EP); C07D 409/12 (2013.01 - EP)
Citation (search report)
See references of WO 9119476A1
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IT LI LU NL SE
DOCDB simple family (publication)
WO 9119476 A1 19911226; AU 650026 B2 19940609; AU 8194391 A 19920107; CA 2084399 A1 19911206; EP 0536316 A1 19930414; EP 0536316 A4 19931118; IE 911909 A1 19911218; IL 98342 A0 19920715; JP H05507496 A 19931028; KR 930700453 A 19930315; NZ 238390 A 19940427; ZA 914285 B 19930224
DOCDB simple family (application)
US 9103854 W 19910531; AU 8194391 A 19910531; CA 2084399 A 19910531; EP 91913532 A 19910531; IE 190991 A 19910605; IL 9834291 A 19910603; JP 51227291 A 19910531; KR 920703102 A 19921204; NZ 23839091 A 19910604; ZA 914285 A 19910605